Khurram Jamil
CIK 2032345 · View on SEC EDGAR ↗
Insider
First SEC filing: Aug. 5, 2024 · Latest: Aug. 5, 2024
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
17 sells (S)
Net:
$-1,435,942
+ 34 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
34 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 14, 2026 | GALT | S 10b5-1 | 16,250 | $5.13 | $83,362 | 0 Direct | -100.00% | Disposed | -28.5% (price as of 2026-08-19) |
| June 29, 2026 | GALT | S 10b5-1 | 47,467 | $5.04 | $239,234 | 0 Direct | -100.00% | Disposed | -27.2% (price as of 2026-08-19) |
| June 26, 2026 | GALT | S 10b5-1 | 2,533 | $5.00 | $12,665 | 0 Direct | -100.00% | Disposed | -26.6% (price as of 2026-08-19) |
| June 26, 2026 | GALT | S 10b5-1 | 2,037 | $5.00 | $10,185 | 0 Direct | -100.00% | Disposed | -26.6% (price as of 2026-08-19) |
| June 23, 2026 | GALT | S 10b5-1 | 7,557 | $3.14 | $23,729 | 0 Direct | -100.00% | Disposed | 16.9% (price as of 2026-08-19) |
| May 26, 2026 | GALT | S 10b5-1 | 568 | $3.10 | $1,761 | 0 Direct | -100.00% | Disposed | 18.4% (price as of 2026-08-19) |
| Jan. 6, 2026 | GALT | S 10b5-1 | 21,446 | $3.65 | $78,278 | 0 Direct | -100.00% | Disposed | 0.5% (price as of 2026-08-19) |
| Jan. 5, 2026 | GALT | S 10b5-1 | 25,499 | $3.90 | $99,446 | 21,446 Direct | -54.32% | Disposed | -5.9% (price as of 2026-08-19) |
| Jan. 2, 2026 | GALT | S 10b5-1 | 13,055 | $4.20 | $54,831 | 46,945 Direct | -21.76% | Disposed | -12.6% (price as of 2026-08-19) |
| Dec. 31, 2025 | GALT | S 10b5-1 | 8,125 | $4.07 | $33,069 | 0 Direct | -100.00% | Disposed | -9.8% (price as of 2026-08-19) |
| Dec. 17, 2025 | GALT | S 10b5-1 | 8,500 | $7.04 | $59,840 | 0 Direct | -100.00% | Disposed | -47.9% (price as of 2026-08-19) |
| Dec. 17, 2025 | GALT | S 10b5-1 | 6,463 | $7.04 | $45,500 | 0 Direct | -100.00% | Disposed | -47.9% (price as of 2026-08-19) |
| Dec. 17, 2025 | GALT | S 10b5-1 | 4,479 | $7.04 | $31,532 | 0 Direct | -100.00% | Disposed | -47.9% (price as of 2026-08-19) |
| Nov. 13, 2025 | GALT | S 10b5-1 | 16,250 | $5.47 | $88,888 | 4,479 Direct | -78.39% | Disposed | -32.9% (price as of 2026-08-19) |
| Nov. 13, 2025 | GALT | S 10b5-1 | 41,500 | $5.47 | $227,005 | 4,479 Direct | -90.26% | Disposed | -32.9% (price as of 2026-08-19) |
| Nov. 13, 2025 | GALT | S 10b5-1 | 41,500 | $5.47 | $227,005 | 4,479 Direct | -90.26% | Disposed | -32.9% (price as of 2026-08-19) |
| Nov. 13, 2025 | GALT | S 10b5-1 | 21,867 | $5.47 | $119,612 | 4,479 Direct | -83.00% | Disposed | -32.9% (price as of 2026-08-19) |
| Dec. 23, 2024 | GALT | S 10b5-1 | 13,654 | $0.88 | $12,016 | 26,346 Direct | -34.13% | Disposed | 317.0% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 14, 2026 | GALT | Stock option (right to buy) | Common Stock (16,250) | $3.04 | Jan. 16, 2036 | 16,250 | Disposed |
| June 29, 2026 | GALT | Stock Option (right to buy) | Common Stock (47,467) | $2.50 | Aug. 1, 2034 | 47,467 | Disposed |
| June 26, 2026 | GALT | Stock Option (right to buy) | Common Stock (2,533) | $2.50 | Aug. 1, 2034 | 2,533 | Disposed |
| June 26, 2026 | GALT | Stock option (right to buy) | Common Stock (2,037) | $2.20 | March 20, 2034 | 2,037 | Disposed |
| June 23, 2026 | GALT | Stock option (right to buy) | Common Stock (7,557) | $1.23 | Jan. 23, 2035 | 7,557 | Disposed |
| May 26, 2026 | GALT | Stock option (right to buy) | Common Stock (568) | $1.23 | Jan. 23, 2035 | 568 | Disposed |
| Jan. 16, 2026 | GALT | Stock option (right to buy) [F1] | Common Stock (65,000) | $3.04 | Jan. 16, 2036 | 65,000 | Acquired |
| Jan. 16, 2026 | GALT | Restricted Stock Unit [F1] | Common Stock (100,000) | — | — | 100,000 | Acquired |
| Jan. 1, 2026 | GALT | Restricted Stock Unit | Common Stock (60,000) | — | — | 60,000 | Disposed |
| Dec. 31, 2025 | GALT | Stock option (right to buy) | Common Stock (8,500) | $1.23 | Jan. 23, 2035 | 8,125 | Disposed |
| Dec. 17, 2025 | GALT | Stock option (right to buy) | Common Stock (8,500) | $2.50 | Aug. 1, 2034 | 8,500 | Disposed |
| Dec. 17, 2025 | GALT | Stock option (right to buy) | Common Stock (6,364) | $2.20 | March 20, 2034 | 6,463 | Disposed |
| Nov. 13, 2025 | GALT | Stock option (right to buy) | Common Stock (41,500) | $2.20 | March 20, 2034 | 41,500 | Disposed |
| Nov. 13, 2025 | GALT | Stock option (right to buy) | Common stock (16,250) | $1.23 | Jan. 23, 2035 | 16,250 | Disposed |
| Nov. 13, 2025 | GALT | Stock option (right to buy) | Common Stock (41,500) | $2.50 | Aug. 1, 2034 | 41,500 | Disposed |
| Jan. 23, 2025 | GALT | Restricted Stock Unit | Common Stock (60,000) | — | — | 60,000 | Acquired |
| Jan. 23, 2025 | GALT | Stock Option (right to buy) [F1] | Common Stock (65,000) | $1.23 | Jan. 23, 2035 | 65,000 | Acquired |
| Dec. 23, 2024 | GALT | Restricted Stock Units [F3] | Common Stock (40,000) | — | — | 40,000 | Acquired |
| Aug. 1, 2024 | GALT | Restricted Stock Unit | Common Stock (10,000) | — | — | 10,000 | Acquired |
| Aug. 1, 2024 | GALT | Stock Option (right to buy) [F1] | Common Stock (100,000) | $2.50 | Aug. 1, 2034 | 100,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
GALT
M.D., Chief Medical Officer(5)| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $365,909 | $120,625 | — | — | — | — | $60,813 | $945,847 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.